KORU COO reports RSU vesting and tax withholding

KORU Medical Systems Chief Operating Officer Christopher Pazdan reported routine equity compensation activity.

Rhea-AI Filing Summary

KORU Medical Systems Chief Operating Officer Christopher Pazdan reported routine equity compensation activity. On the vesting of restricted stock units, he acquired 5,327 shares of common stock and 1,470 shares were withheld to satisfy tax obligations at a value of $3.94 per share. Following these transactions, he holds just over 310,000 shares directly.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Pazdan Christopher

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Exercise	Common Stock	5,327	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	1,470	$3.94	$6K

Holdings After Transaction: Common Stock — 308,988 shares (Direct)

Footnotes (2)

1. F1. Represents common stock issued upon vesting of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock upon vesting.
2. F2. Represents shares withheld to satisfy tax obligations upon vesting of restricted stock units.

Key Figures

Tax-withheld shares: 1,470 shares RSU vesting shares: 5,327 shares Tax withholding price: $3.94 per share +2 more

5 metrics

Tax-withheld shares 1,470 shares Shares withheld to satisfy tax obligations at $3.94 per share

RSU vesting shares 5,327 shares Common stock issued upon vesting of restricted stock units

Tax withholding price $3.94 per share Implied value for shares withheld for tax obligations

Post-transaction holdings (entry 1) 308,988 shares Direct common stock ownership after tax-withholding disposition

Post-transaction holdings (entry 2) 310,458 shares Direct common stock ownership after RSU-related acquisition

Key Terms

restricted stock units, tax obligations, derivative exercise/conversion, tax-withholding disposition

4 terms

restricted stock units financial

"Represents common stock issued upon vesting of restricted stock units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax obligations financial

"Represents shares withheld to satisfy tax obligations upon vesting of restricted stock units."

derivative exercise/conversion financial

"transaction_action": "derivative exercise/conversion""

tax-withholding disposition financial

"transaction_action": "tax-withholding disposition""

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did KORU Medical Systems (KRMD) report for Christopher Pazdan?

KORU Medical Systems reported that Chief Operating Officer Christopher Pazdan received 5,327 common shares from restricted stock unit vesting, while 1,470 shares were withheld to cover tax obligations. These are compensation-related entries rather than open-market stock purchases or sales.

Was the KORU Medical Systems (KRMD) Form 4 transaction an open-market sale or purchase?

The Form 4 does not show any open-market buy or sell. Instead, it records restricted stock units vesting into 5,327 common shares and a tax-withholding disposition of 1,470 shares, which is a standard, non-market mechanism to satisfy tax liabilities.

How many KORU Medical Systems (KRMD) shares does Christopher Pazdan hold after this Form 4?

After these compensation-related transactions, Christopher Pazdan holds slightly more than 310,000 KORU Medical Systems common shares directly. The Form 4 shows post-transaction ownership amounts of 308,988 and 310,458 shares tied to the respective entries on the reported date.

What does the tax-withholding entry mean in the KRMD Form 4 for Christopher Pazdan?

The tax-withholding entry shows 1,470 KORU shares were withheld at $3.94 each to pay Pazdan’s tax obligations when restricted stock units vested. This disposition is not an open-market sale, but an administrative step handled by the company.

What role do restricted stock units play in KORU Medical Systems (KRMD) executive compensation?

The filing indicates that restricted stock units provide a contingent right to receive one KORU common share upon vesting. In this case, vested units delivered 5,327 shares to Chief Operating Officer Christopher Pazdan as part of his equity-based compensation package.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/18/2026 - 04:39 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pazdan Christopher

(Last) (First) (Middle)

C/O KORU MEDICAL SYSTEMS, INC.

100 CORPORATE DRIVE

(Street)

MAHWAH NEW JERSEY 07430

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
KORU Medical Systems, Inc. [ KRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/14/2026		M		5,327	A	$0(1)	310,458	D
Common Stock	05/14/2026		F(2)		1,470	D	$3.94	308,988	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents common stock issued upon vesting of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock upon vesting.

2. Represents shares withheld to satisfy tax obligations upon vesting of restricted stock units.

Remarks:

The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person. Power of Attorney has been previously filed.

	/s/ Thomas Adams - Attorney-in-Fact	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)